Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study

Teratology
Orna Diav-CitrinAsher Ornoy

Abstract

Metronidazole is an important antibacterial agent commonly used in women of reproductive age. Its use in pregnancy is a reason for concern for women and their health care providers. The objective was to examine the fetal safety of metronidazole. The Israeli Teratogen Information Service prospectively collected and followed up 228 women exposed to metronidazole in pregnancy, 86.2% of whom with first-trimester exposure. Pregnancy outcome was compared with that of a control group, who were counseled during the same period for nonteratogenic exposure. There was no difference in the rate of major malformations between the groups (3/190; 1.6% [metronidazole] vs. 8/575; 1.4% [control], P = 0.739). The rate of major malformations did not differ between the groups even after including elective terminations of pregnancy due to prenatally diagnosed malformations (5/192; 2.6% [metronidazole] vs. 12/579; 2.1% [control], P = 0.777). A reduced neonatal birth weight was found in the metronidazole group compared with controls without significant differences in the rate of prematurity or in gestational age at delivery. The mean birth weight was lower in the metronidazole group when comparing the subgroup of term infants. This study confirms that...Continue Reading

References

Jan 1, 1978·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·I Morgan
Sep 6, 1979·The New England Journal of Medicine·C M BeardM B Dockerty
Dec 1, 1985·American Journal of Medical Genetics·F Greenberg
Feb 1, 1966·American Journal of Obstetrics and Gynecology·R X Sands
Apr 1, 1983·American Journal of Obstetrics and Gynecology·M O Robbie, R L Sweet
Oct 1, 1980·Annals of Internal Medicine·S M Finegold
Feb 1, 1995·American Journal of Obstetrics and Gynecology·P BurtinG Koren
Aug 1, 1997·British Journal of Clinical Pharmacology·T Caro-PatónE Rodríguez Pinilla
Feb 14, 1998·BMJ : British Medical Journal·M EggerG Davey Smith
Apr 9, 1998·British Journal of Obstetrics and Gynaecology·A E Czeizel, M Rockenbauer
Oct 8, 1998·Reproductive Toxicology·A OrnoyI Lukashova
Aug 10, 1999·Teratology·M L Martínez-Frías, E Rodríguez-Pinilla
Apr 25, 2000·Teratology·A Ornoy, P Mastroiacovo
Feb 1, 1964·The Journal of Obstetrics and Gynaecology of the British Commonwealth·M SCOTT-GRAY

❮ Previous
Next ❯

Citations

Jul 16, 2008·Inflammatory Bowel Diseases·Marla DubinskyUma Mahadevan
Aug 21, 2009·Inflammatory Bowel Diseases·Stephen B Hanauer
Jun 6, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Elizabeth Ann Conover
Mar 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen A Wendel, Kimberly A Workowski
Jul 4, 2012·Antimicrobial Agents and Chemotherapy·Catherine A KossEmilia H Koumans
Feb 16, 2005·Digestion·Christian MottetChristian Felley
Feb 2, 2008·Digestion·Christian MottetChristian Felley
Aug 16, 2002·American Journal of Clinical Dermatology·Alfredo Rebora
Jul 31, 2013·Nature Reviews. Gastroenterology & Hepatology·Ole Haagen NielsenJakob Hendel
Jan 31, 2006·Expert Review of Anti-infective Therapy·Neha NandaKaren A Wendel
Feb 9, 2013·Expert Review of Clinical Immunology·Susie W Ng, Uma Mahadevan
Jul 3, 2010·Expert Review of Clinical Immunology·Lola Y Kwan, Uma Mahadevan
Aug 19, 2007·Expert Opinion on Pharmacotherapy·Angel A Escobedo, Sergio Cimerman
Oct 17, 2009·Expert Opinion on Drug Safety·Matteo CassinaMaurizio Clementi
Sep 8, 2005·Expert Opinion on Pharmacotherapy·Jenny Sauk, Sunanda Kane
Mar 12, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Andres Yarur, Sunanda V Kane
Aug 23, 2011·Journal of the American College of Surgeons·Jacqueline J ChoiCelia M Divino
Feb 5, 2010·Gastroenterología y hepatología·Elena GarridoAntonio López-Sanromán
Dec 1, 2009·The Medical Clinics of North America·Uma Mahadevan
Nov 17, 2009·Gastroenterology Clinics of North America·Uma Mahadevan
Oct 22, 2008·Reproductive Toxicology·Gian Mario TiboniAnna Pia Castigliego
Sep 25, 2007·Best Practice & Research. Clinical Gastroenterology·Dana C Moffatt, Charles N Bernstein
Sep 25, 2007·Best Practice & Research. Clinical Gastroenterology·Uma Mahadevan
Dec 23, 2006·Reproductive Toxicology·Marta D MudryMarta A Carballo
Apr 22, 2006·Environmental and Molecular Mutagenesis·José Manuel Ornelas-AguirreGuillermo M Zúñiga-González
Jul 31, 2007·Alimentary Pharmacology & Therapeutics·Z S HeetunC O'Morain
Feb 13, 2007·Travel Medicine and Infectious Disease·I Dale Carroll, Alfons Van Gompel
Jun 5, 2004·Gastroenterology Clinics of North America·Adam F Steinlauf, Daniel H Present
Jan 28, 2003·American Journal of Obstetrics and Gynecology·Orna Diav-CitrinAsher Ornoy
Oct 29, 2008·Infectious Disease Clinics of North America·Paul Nyirjesy
Feb 19, 2013·Mutation Research·Lopamudra Das RoyAnirudha Giri
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Dec 21, 2006·The American Journal of Gastroenterology·Joyann Kroser, Radhika Srinivasan
Apr 27, 2019·Dermatologic Therapy·Viral M PatelW Clark Lambert
Feb 10, 2017·Current Treatment Options in Gastroenterology·Jill K J Gaidos, Sunanda V Kane
Oct 31, 2003·Expert Opinion on Drug Safety·Janelle M WrightJacqueline A Upcroft
Oct 26, 2002·The Annals of Pharmacotherapy·Stephen D H Malnick, Oren Zimhony
Jun 18, 2021·European Journal of Obstetrics & Gynecology and Reproductive Biology: X·Priscilla AjijiPatrick Maison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.